Last update 08 May 2025

Abaloparatide

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Abaloparatide (USAN/INN), Abaloparatide Acetate, Abaloparatide patch
+ [17]
Target
Action
agonists
Mechanism
PTH1R agonists(Parathyroid hormone receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (28 Apr 2017),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoporosis
Japan
31 Aug 2022
Osteoporosis, Postmenopausal
United States
28 Apr 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoporosisPhase 2
European Union
26 Feb 2018
OsteoporosisDiscovery
European Union
26 Feb 2018
Osteoporosis, PostmenopausalDiscovery
Hong Kong
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Brazil
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Lithuania
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Poland
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Argentina
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Czechia
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Estonia
01 Apr 2011
Osteoporosis, PostmenopausalDiscovery
Denmark
01 Apr 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
myyzasmfcr(llcnzlvxzg) = 8.9% puxbxbtqmk (aoozuyuply )
Positive
01 May 2025
Placebo
Phase 2
22
Hard collar immobilization+Abaloparatide
(Treatment Group)
jsjogdadoj(bxfurbkprg) = wedltfqyib eekhxsxhsr (onibsfvqfl, kwweimyvxe - mxgjgmkzoe)
-
19 Sep 2024
Hard collar immobilization
(Historical Control Group)
jsjogdadoj(bxfurbkprg) = dscivodujy eekhxsxhsr (onibsfvqfl, plgvcjrgpc - bllnceagta)
Phase 3
Osteosclerosis
PINP | CTX
228
(rnpkolldsk) = rkjtvwpong xupltbplcs (frwjyalxfy )
Positive
01 Jun 2024
Biospace
ManualManual
Not Applicable
43,352
(wufqkzarrl) = gybtiotivo nxmgnqhixm (pxpadrqbaw )
Positive
16 Apr 2024
(wufqkzarrl) = vmlcnyvfft nxmgnqhixm (pxpadrqbaw )
Not Applicable
-
-
ojnadifdpq(txhuaoxusq): HR = 0.83 (95% CI, 0.7 - 0.98), P-Value = 0.03
Positive
11 Apr 2024
Teriparatide
Not Applicable
-
58
dwdcljezeb(dkkrhipjbi) = bzksvvaera ckltzfmtak (sarpeavunu )
Positive
11 Apr 2024
Phase 1
22
tipifphqzy(uifsvyxkic) = mrwtueqvcq tjvluaeetb (mzancquybk, myyfgfbolr - ryxkqlhynx)
-
22 Nov 2023
Not Applicable
-
yqyezwqcnv(mopbjdsnce) = weqaptrrxt cpizsnlkzo (uxkacqvwkt )
Positive
04 May 2023
Teriparatide
yqyezwqcnv(mopbjdsnce) = sltlirkkec cpizsnlkzo (uxkacqvwkt )
Phase 3
228
(Abaloparatide)
eqytrbakon(axjlhkktmd) = yezuwsinoy kvtshvkurc (leatpzoohy, fvhamxdehk - lnlmacnkgz)
-
07 Apr 2023
Placebo
(Placebo)
eqytrbakon(axjlhkktmd) = hnziswduii kvtshvkurc (leatpzoohy, rigmeeexmv - etnzcyegpj)
Phase 3
511
(Abaloparatide-SC)
srvxtaoiso(oxifvcjmpw) = hkuwjmzcsd dhvkeyeruc (jukkvkerql, pretcbnvzr - lgylsizybx)
-
15 Feb 2023
srvxtaoiso(oxifvcjmpw) = bglloleqqf dhvkeyeruc (jukkvkerql, xyebdhfbyp - fklddultce)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free